Safety evaluation of substances consumed as technical ingredients (food additives)
- 1 March 1991
- journal article
- review article
- Published by Taylor & Francis in Food Additives & Contaminants
- Vol. 8 (2) , 125-133
- https://doi.org/10.1080/02652039109373963
Abstract
The different types of acceptable daily intakes (ADIs) are described as used by the FAO/WHO Expert Committee on Food Additives (JECFA) and the EEC Scientific Committee for Food (SCF). The allocation is discussed of a full ADI or a temporary ADI, and examples are given for the establishment (or withdrawal) of these ADIs. The flavours cinnamyl anthranillate and the solvent 2‐nitropropane (both withdrawn), the sweeteners cyclamate and saccharin and the antioxidant BHA (all three changed) but not abolished. For BHA and saccharin the ADI was retained by both committees in spite of some evidence of carcinogenicity to experimental animals. ADI—'not specified’ is specially discussed and it is recommended that numerical ADIs are used whenever possible. With an ADI—'not specified’ it should be stated which use (and intake) levels are toxicologically acceptable. Some compounds evaluated by the two committees are discussed, e.g. the colours: Allura red AC, erythrosine, canthaxanthin and the caramels; three anti‐oxidants: BHA, BHT and the gallates; the sweeteners: polyols, aspartame, saccharin and cyclamates. Four recommendations are made: (1) a numerical basis be given for the levels allocated an ADI—'not specified’ or ‘acceptable'; (2) lowering of the conventional safety factor be considered when the effects found are trivial—higher safety factors be considered when the toxic effects are serious or even irreversible; (3) ADIs should, whenever possible, be based on a combination of human and animal data; (4) ADIs might be allocated to compounds indicating animal carcinogenicity, if the compound is non‐genotoxic, the mechanism clearly secondary and/or species‐specific.Keywords
This publication has 3 references indexed in Scilit:
- Hepatocellular Tumorigenicity of Butylated Hydroxytoluene Administered Orally to B6C3F1 MiceJapanese Journal of Cancer Research, 1988
- Carcinogenicity study on butylated hydroxytoluene (BHT) in Wistar rats exposed in uteroFood and Chemical Toxicology, 1986
- Toxicological aspects of cyclamate and cyclohexylamineCRC Critical Reviews in Toxicology, 1986